Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Breast Cancer
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Screening
Participation Requirements
- Age
- Between 40 years and 125 years
- Gender
- Only males
Description
The goal of this program will be to bring 6-8 mobile on site mammography clinics to homeless shelters that house women across the greater Cleveland and surrounding communities over a two-year period. Prior to arrival, clinic staff will recruit women to participate in a survey to elucidate beliefs an...
The goal of this program will be to bring 6-8 mobile on site mammography clinics to homeless shelters that house women across the greater Cleveland and surrounding communities over a two-year period. Prior to arrival, clinic staff will recruit women to participate in a survey to elucidate beliefs and barriers around breast health and mammography. After the survey, clinic staff will conduct the outreach program, consisting of a brief educational session about breast health and mammography for any participating women. Education will be tailored to be culturally appropriate, and delivered by a female public health educator with experience in the underserved community. The educational session will explain screening options and address common barriers. After education, eligible women who wish to receive a mammogram may receive one from the on-site mobile mammography clinic free of charge. Throughout the day, the community educator will also lead activities and meals will be provided in order to create a festive atmosphere and inspire a sense of community among the women. Spanish speaking staff will be available for the educational sessions.
Tracking Information
- NCT #
- NCT04348123
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Chirag Shah, MD Cleveland Clinic, Case Comprehensive Cancer Center